The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort.
 
Jack Patrick Gleeson
Honoraria - IQvia
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Andrea Knezevic
No Relationships to Disclose
 
Maria Bromberg
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Joel Sheinfeld
No Relationships to Disclose
 
Brett Stewart Carver
No Relationships to Disclose
 
David Randolph Jones
Consulting or Advisory Role - AstraZeneca; Diffusion Pharmaceuticals; Merck
 
Manjit S. Bains
No Relationships to Disclose
 
Dean F. Bajorin
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Dragonfly Therapeutics; Fidia Farmaceutici S. p. A.; Merck; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
Travel, Accommodations, Expenses - Merck; Roche/Genentech
 
George J. Bosl
No Relationships to Disclose
 
Deaglan Joseph McHugh
Consulting or Advisory Role - Progenics
 
Samuel Aaron Funt
Stock and Other Ownership Interests - Allogene Therapeutics; Kite, a Gilead company; Kronos Bio (I); Neogene Therapeutics (I); Urogen pharma (I); Vaxigene Therapeutics; Vaxigene Therapeutics; Vida Ventures (I)
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Immunai; Merck
Research Funding - AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Darren R. Feldman
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate